av/titan-medical--big.svg

NASDAQ:TMDI

Titan Medical Inc

  • Stock

USD

Last Close

0.05

15/10 17:23

Market Cap

5.70M

Beta: 3.52

Volume Today

117.22K

Avg: 3.88M

PE Ratio

−0.51

PFCF: −0.77

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
68.95K
-
102.19K
48.20%
108.03K
5.72%
74.80K
30.76%
-873.50K
-
average payables
2.23M
-
7.96M
256.45%
7.85M
1.30%
2.89M
63.16%
5.80M
100.30%
4.40M
24.06%
3.50M
-
3.63M
3.76%
average receivables
90.23K
-
100.04K
10.87%
116.88K
16.83%
125.58K
7.44%
109.19K
13.05%
113.66K
4.10%
77.83K
31.52%
4.18M
5,265.16%
5.01M
20.06%
919.50K
81.66%
book value per share
9.45
-
-0.12
101.25%
0.12
202.86%
1.22
899.17%
0.25
79.15%
-0.38
250.15%
-0.21
45.86%
0.33
257.92%
0.04
-
capex per share
-0.04
-
-0.04
13.35%
-0.03
3.62%
-0.03
23.24%
-0.03
2.50%
-0.01
40.97%
-0.01
40.07%
-0.01
22.16%
-0.00
-
capex to depreciation
-5.36
-
-3.76
29.84%
-6.70
78.06%
-11.80
76.18%
-14.48
22.74%
-14.07
2.85%
-2.53
82.01%
-1.08
57.32%
-1.19
9.94%
-1.15
3.56%
capex to operating cash flow
0.01
-
0.00
63.97%
0.00
32.09%
0.01
128.88%
0.01
5.32%
0.01
1.91%
0.71
7,016.39%
0.02
97.09%
0.04
79.38%
-0.05
223.03%
capex to revenue
-0.03
-
-0.04
25.38%
-0.01
-
cash per share
10.82
-
3.22
70.22%
0.89
72.42%
3.31
272.35%
0.69
79.15%
0.03
96.15%
0.38
1,332.12%
0.30
21.62%
0.07
-
days of inventory on hand
days payables outstanding
days sales outstanding
1.31
-
150.41
11,416.19%
1.90
-
debt to assets
0.01
-
0.09
992.32%
0.03
70.08%
0.24
754.27%
0.15
37.10%
debt to equity
-0.00
-
-0.20
8,053.33%
0.04
118.53%
-0.54
1,536.56%
0.28
151.19%
dividend yield
earnings yield
-0.12
-
-0.53
345.26%
-0.67
26.48%
-0.48
28.47%
-1.10
129.28%
-2.76
150.83%
-0.22
91.97%
-0.21
4.67%
1.02
-
enterprise value
86.84M
-
66.94M
22.91%
30.46M
54.51%
43.92M
44.22%
9.12M
79.23%
14.57M
59.66%
91.52M
528.27%
39.43M
56.92%
-1.58M
104.01%
600.80K
138.03%
enterprise value over ebitda
-5.94
-
-1.59
73.16%
-0.95
40.60%
-8.46
794.06%
-0.16
98.13%
-0.24
50.59%
34.58
14,632.57%
-1.33
103.85%
0.06
-
ev to operating cash flow
-6.74
-
-1.95
71.08%
-0.87
55.64%
-2.30
165.94%
-0.22
90.42%
-0.32
43.81%
-108.29
34,067.52%
-1.08
99.01%
0.06
105.32%
0.13
124.03%
ev to sales
4.58
-
1.96
57.11%
0.03
-
free cash flow per share
-4.15
-
-9.91
139.00%
-7.24
26.95%
-2.44
66.26%
-2.51
2.92%
-1.51
39.83%
-0.02
98.57%
-0.34
1,498.67%
0.04
-
free cash flow yield
-0.12
-
-0.44
283.09%
-1.02
130.57%
-0.28
72.90%
-2.03
637.27%
-3.02
48.91%
-0.01
99.58%
-0.53
4,095.74%
0.66
-
graham net net
9.01
-
-0.57
106.34%
-0.43
25.09%
0.78
283.03%
-0.37
146.92%
-0.46
25.66%
-0.27
41.48%
0.25
190.64%
0.03
-
graham number
30.20
-
5.63
81.35%
3.62
35.80%
10.79
198.30%
2.79
74.17%
3.44
23.36%
1.32
61.52%
1.00
24.26%
0.24
-
income quality
0.96
-
0.83
13.42%
1.51
82.10%
0.57
62.34%
1.83
221.73%
1.10
40.02%
0.03
96.81%
2.46
6,952.54%
0.65
73.70%
0.67
3.85%
intangibles to total assets
0.01
-
0.03
254.62%
0.08
133.31%
0.03
67.87%
0.05
105.06%
0.47
785.34%
0.06
87.42%
0.04
31.80%
0.29
620.01%
0
100%
interest coverage
-144.80
-
2.70
101.86%
-247.90
9,283.56%
21.90
-
interest debt per share
0.01
-
0.06
294.44%
0.01
76.95%
0.01
-
inventory turnover
invested capital
-0.00
-
-0.20
8,053.33%
0.04
118.53%
-0.54
1,536.56%
0.28
151.19%
market cap
113.00M
-
78.14M
30.85%
34.80M
55.47%
70.05M
101.33%
20.59M
70.60%
15.35M
25.46%
114.18M
643.78%
70.41M
38.34%
6.82M
-
net current asset value
29.26M
-
-864.35K
102.95%
1.14K
100.13%
8.83M
773,419.63%
3.04M
65.50%
-13.31M
537.29%
-16.70M
25.43%
31.73M
290.02%
-5.25M
116.53%
4.68M
189.27%
net debt to ebitda
1.79
-
0.27
85.10%
0.13
49.40%
5.03
3,632.50%
0.20
96.05%
0.01
93.54%
-8.57
66,854.88%
1.05
112.22%
-0.58
-
net income per share
-4.29
-
-11.92
177.78%
-4.77
59.93%
-4.25
10.94%
-1.36
67.99%
-1.38
1.35%
-0.38
72.65%
-0.14
63.68%
0.06
-
operating cash flow per share
-4.11
-
-9.87
140.50%
-7.21
27.03%
-2.42
66.46%
-2.49
2.98%
-1.50
39.82%
-0.01
99.16%
-0.34
2,577.26%
0.04
-
payables turnover
receivables turnover
279.46
-
2.43
99.13%
191.65
-
research and ddevelopement to revenue
0.40
-
1.89
375.98%
0.02
-
return on tangible assets
-0.38
-
-3.33
767.47%
-3.53
6.00%
-1.16
67.07%
-1.09
6.09%
-23.78
2,079.07%
-0.90
96.21%
-0.33
63.59%
0.79
-
revenue per share
0.30
-
0.19
37.92%
0.16
-
roe
-0.45
-
100.70
22,279.03%
-39.23
138.95%
-3.50
91.09%
-5.37
53.55%
3.62
167.50%
1.83
49.49%
-0.42
123.00%
1.45
-
roic
-0.45
-
100.69
22,346.80%
-37.95
137.69%
-2.83
92.55%
-3.17
12.20%
5.32
267.84%
-0.31
105.73%
-0.82
168.68%
0.65
-
sales general and administrative to revenue
0.37
-
0.62
65.17%
0.47
-
shareholders equity per share
9.45
-
-0.12
101.25%
0.12
202.86%
1.22
899.17%
0.25
79.15%
-0.38
250.15%
-0.21
45.86%
0.33
257.92%
0.04
-
stock based compensation to revenue
0.05
-
0.20
266.09%
0.06
-
tangible asset value
29.28M
-
-859.83K
102.94%
10.49K
101.22%
8.83M
84,091.91%
3.04M
65.53%
-13.28M
536.30%
-15.59M
17.34%
33.37M
314.11%
-5.25M
115.72%
4.79M
191.19%
tangible book value per share
9.34
-
-0.25
102.65%
0.00
100.87%
1.12
51,966.47%
0.18
83.63%
-0.43
336.49%
-0.23
46.26%
0.31
232.30%
0.04
-
working capital
29.26M
-
-864.35K
102.95%
1.14K
100.13%
8.83M
773,419.63%
3.04M
65.50%
-13.31M
537.03%
-15.95M
19.86%
32.77M
305.47%
-3.82M
111.67%
5.54M
244.87%

All numbers in USD (except ratios and percentages)